Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew M Stern

Showing results (51-60 of 87) with videos related to

Pageof 9
Sort By:
Platelets|July 10, 2003
Effects of the glycoprotein IIb/IIIa antagonist Roxifiban on P-selectin expression, fibrinogen binding, and microaggregate formation in a phase I dose-finding study: no evidence for platelet activation during treatment with a glycoprotein IIb/IIIa antagonistDietmar Seiffert, Beth E Thomas, Jodi D Bradley, et al.
Acta Neuropathologica|October 14, 2025
Genetic and proteomic analysis identifies BAG3 as an amyloid-responsive regulator of neuronal proteostasisZachary M Augur, Garrett M Fogo, Mason R Arbery, et al.
Journal of Pathology Informatics|December 21, 2016
Pointwise mutual information quantifies intratumor heterogeneity in tissue sections labeled with multiple fluorescent biomarkersDaniel M Spagnolo, Rekha Gyanchandani, Yousef Al-Kofahi, et al.
Medrxiv : the Preprint Server for Health Sciences|March 22, 2023
Plasma NT1-tau and Aβ <sub>42</sub> correlate with age and cognitive function in two large Down syndrome cohortsAndrew M Stern, Kathryn L Van Pelt, Lei Liu, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 13, 2023
Plasma NT1-tau and Aβ<sub>42</sub> correlate with age and cognitive function in two large Down syndrome cohortsAndrew M Stern, Kathryn L Van Pelt, Lei Liu, et al.
Molecular Cancer Research : MCR|April 3, 2020
Targeting NAD<sup>+</sup> Biosynthesis Overcomes Panobinostat and Bortezomib-Induced Malignant Glioma ResistanceEsther P Jane, Daniel R Premkumar, Swetha Thambireddy, et al.
Breast Cancer Research : BCR|May 25, 2017
Mutation site and context dependent effects of ESR1 mutation in genome-edited breast cancer cell modelsAmir Bahreini, Zheqi Li, Peilu Wang, et al.
Nature|July 15, 2011
Selective killing of cancer cells by a small molecule targeting the stress response to ROSLakshmi Raj, Takao Ide, Aditi U Gurkar, et al.
Nature|September 17, 2015
Corrigendum: Selective killing of cancer cells by a small molecule targeting the stress response to ROSLakshmi Raj, Takao Ide, Aditi U Gurkar, et al.
Nature|July 27, 2018
Retraction Note: Selective killing of cancer cells by a small molecule targeting the stress response to ROSLakshmi Raj, Takao Ide, Aditi U Gurkar, et al.
Pageof 9

Showing results (51-60 of 87) with videos related to

Sort By:
Pageof 9
Platelets|July 10, 2003
Effects of the glycoprotein IIb/IIIa antagonist Roxifiban on P-selectin expression, fibrinogen binding, and microaggregate formation in a phase I dose-finding study: no evidence for platelet activation during treatment with a glycoprotein IIb/IIIa antagonistDietmar Seiffert, Beth E Thomas, Jodi D Bradley, et al.
Acta Neuropathologica|October 14, 2025
Genetic and proteomic analysis identifies BAG3 as an amyloid-responsive regulator of neuronal proteostasisZachary M Augur, Garrett M Fogo, Mason R Arbery, et al.
Journal of Pathology Informatics|December 21, 2016
Pointwise mutual information quantifies intratumor heterogeneity in tissue sections labeled with multiple fluorescent biomarkersDaniel M Spagnolo, Rekha Gyanchandani, Yousef Al-Kofahi, et al.
Medrxiv : the Preprint Server for Health Sciences|March 22, 2023
Plasma NT1-tau and Aβ <sub>42</sub> correlate with age and cognitive function in two large Down syndrome cohortsAndrew M Stern, Kathryn L Van Pelt, Lei Liu, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 13, 2023
Plasma NT1-tau and Aβ<sub>42</sub> correlate with age and cognitive function in two large Down syndrome cohortsAndrew M Stern, Kathryn L Van Pelt, Lei Liu, et al.
Molecular Cancer Research : MCR|April 3, 2020
Targeting NAD<sup>+</sup> Biosynthesis Overcomes Panobinostat and Bortezomib-Induced Malignant Glioma ResistanceEsther P Jane, Daniel R Premkumar, Swetha Thambireddy, et al.
Breast Cancer Research : BCR|May 25, 2017
Mutation site and context dependent effects of ESR1 mutation in genome-edited breast cancer cell modelsAmir Bahreini, Zheqi Li, Peilu Wang, et al.
Nature|July 15, 2011
Selective killing of cancer cells by a small molecule targeting the stress response to ROSLakshmi Raj, Takao Ide, Aditi U Gurkar, et al.
Nature|September 17, 2015
Corrigendum: Selective killing of cancer cells by a small molecule targeting the stress response to ROSLakshmi Raj, Takao Ide, Aditi U Gurkar, et al.
Nature|July 27, 2018
Retraction Note: Selective killing of cancer cells by a small molecule targeting the stress response to ROSLakshmi Raj, Takao Ide, Aditi U Gurkar, et al.
Pageof 9